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Abstract
Background: Podiatrists routinely perform non-invasive lower limb vascular assessment, however frequently cite
time as a major barrier in performing regular assessment. The aim of this study was to develop an evidence-based
vascular assessment method to guide podiatrists’ decision-making processes to aid in timely vascular assessment in
at risk populations.
Method: The sample underwent brachial pressure measurement, ankle pressures, toe pressure and Doppler
waveform with colour duplex ultrasound (CFDU) used as the reference standard. Both the targeted screening
method and the American Heart Association (AHA) guideline for vascular screening were then applied to the data
set and sensitivity and specificity of each method was calculated.
Results: One hundred nineteen participants were included. Sensitivity of the targeted screening method (62%, 95% CI
47.17–75.35) was higher than the AHA method (49%, 95% CI 34.75–63.40), however, specificity of the AHA method
(94%, 95% CI 85.62–98.37) was higher than the targeted screening method (85%, 95% CI 74.26–92.60). Diagnostic
accuracy was similar with the AHA method yielding 74% diagnostic accuracy and the targeted screening method 73%.
Conclusion: The targeted screening method and the broad international guideline demonstrated similar accuracy,
however clinicians may save time using the targeted screening method. This study highlights the difficulties in
obtaining accuracy in lower limb vascular assessment in general.
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Background
Identifying the presence and extent of peripheral arterial
disease (PAD) through accurate lower limb vascular as-
sessment is essential for reducing morbidity and mortal-
ity associated with the disease [1]. Through early
identification of PAD, complications such as ulceration,
gangrene and amputation can be reduced or avoided
using aggressive risk factor modification, provision of
ongoing foot care and foot care education [2–4]. It has
been estimated that up to 90% of amputations are pre-
ventable [2–4] with adequate foot screening including
vascular assessment playing a vital role in reducing com-
plications and improving clinical outcomes [1]. Accurate
and effective vascular assessment requires a complex
reasoning process which takes into account a patient’s
vascular risk factors as well as an awareness of the effect
of co-morbidities on the clinical efficacy of assessments
techniques, and, subsequent interpretation of results to
formulate an evidence-based management plan.
Podiatrists play a central role in conducting non-
invasive lower limb vascular assessments in the general
population. We have recently demonstrated that on
average, podiatrists perform two vascular assessments
per day, however, the type of the testing that is con-
ducted during the assessments is extremely varied and,
potentially inadequate for accurate PAD screening [2].
There are several available international guidelines for
performing screening for PAD, including National Insti-
tute of Health and Care Excellence (NICE) guidelines
and the American Heart Association (AHA) guidelines.
Both of these guidelines recommend the use of ABI as a
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primary screening tool for populations at risk of PAD [3,
4]. However the uptake of these recommendations into
clinical practice appears to be inconsistent [2]. Time re-
quired to perform recommended objective testing, par-
ticularly the ankle-brachial index (ABI) is the most
widely nominated barrier to conducting appropriate vas-
cular assessment, [2, 5] with clinicians often relying on
more quickly applied assessments including continuous
wave Doppler (CWD) and pulse palpation. In addition
there is growing evidence of the reduced accuracy of the
ABI for detecting PAD in specific populations including
those at risk of medial arterial calcification (MAC), par-
ticularly when co-existing with PAD and of a more distal
distribution of atherosclerotic lesions including diabetes,
renal disease, and older aged cohorts [6]. In such popu-
lations further alternate testing including the toe bra-
chial index (TBI) is frequently required, adding to the
time to complete an assessment. Our recent research
suggests more quickly applied vascular assessment tech-
niques such as the TBI and CWD may be suitable for
use as first line assessment techniques for PAD assess-
ment, particularly in older people and those with dia-
betes [7, 8]. The aim of this study was to determine if a
targeted version of current guidelines in which the TBI
was used initially in patient populations in which the
ABI is known to be problematic could achieve similar
diagnostic accuracy to testing protocols where the ABI is
used as the primary objective testing method for all
people at risk of PAD.
Methods
The CFDU and vascular assessment results of this data
set has previously been used to investigate diagnostic ac-
curacy of vascular testing methods in specific popula-
tions [7, 8]. Participants were recruited on a volunteer
basis from two different locations, a community health
centre in Newcastle, NSW, and a private podiatry prac-
tice in Nelson Bay NSW. Participants who fitted the
AHA guidelines for peripheral vascular screening were
eligible to participate; i.e. patients over the age of 65, pa-
tients above the age of 50 with the presence of diabetes
or currently smoking or patients with exertional leg
pain. Participants who were unable to comply with the
testing protocol or who had a vasospastic disorder pre-
venting TBI measurement were excluded. Testers in-
cluded three vascular sonographers who performed:
colour duplex ultrasound (CFDU), ankle, brachial and
toe pressure measurements, at a private clinic in
Newcastle. Methodology for vascular screening has pre-
viously been described [7, 8]. CFDU reliability has previ-
ously been assessed [8] and found to be acceptable.
An extensive review of the literature was performed.
Combined with recent research completed by the re-
searchers [7, 8] which examined the diagnostic accuracy
of the ABI, TBI and CWD in different populations at
risk of PAD, a targeted vascular assessment method was
developed that is applied based on a patient’s medical
history (Fig. 1). The targeted method used the patient’s
risk factors for PAD combined with the known limita-
tions of the ABI to assist the clinician choose the most
accurate vascular test in the specific patient population
being assessed. In the targeted method the presence of
diabetes and/or renal disease, or being of advanced age
were used as a prompt for the clinician to perform a TBI
due to the reduced diagnostic accuracy of the ABI in
these populations [6, 7, 9]. In the targeted method all
other risk factors for PAD led the clinician to perform
an ABI as this has been demonstrated to be an adequate
test in the general population at risk of PAD and, in the
absence of diabetes, renal disease or advanced age [10].
All patients had CWD performed as this is an accessible,
quick and relatively simple test to perform which has
been shown to be reliable and accurate in populations
requiring vascular screening and a useful adjunct to per-
ipheral pressure testing [7, 9, 11, 12]. The targeted
method was then directly compared to the American
Heart Association (AHA) guideline (Fig. 2) [3] to deter-
mine relative diagnostic accuracy of both screening tech-
niques for PAD. Ethics approval was obtained through the
University of Newcastle ethics committee and Hunter
New England Area Health research ethics committee.
Fig. 1 Targeted screening method for non-invasive vascular
assessment of the lower limb
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Experimental procedure
The AHA guideline was applied to the entire data set by
a single researcher (PT) i.e. the ABI result was used un-
less it exceeded 1.4 in which case it was replaced by the
TBI. These results were used to determine the diagnostic
accuracy of the AHA guidelines for detecting PAD using
CFDU as the reference standard. The targeted method
was also applied to the entire data set by a single re-
searcher (PT) i.e. the ABI was used unless diabetes or
renal failure was present or participants were aged over
75 years in which case the TBI value was used. These re-
sults were used to determine the diagnostic accuracy of
the targeted screening method for detecting PAD using
CFDU as a reference standard.
For statistical calculations relating to diagnostic accur-
acy, presence of PAD was defined as one or more arter-
ies with >50% stenosis [13, 14]. Sensitivity, specificity,
positive and negative predictive values and likelihood ra-
tios were calculated with 95% confidence intervals for
the AHA screening method and the targeted screening
method. Calculations of diagnostic accuracy were per-
formed using Microsoft Excel.
Results
A total of 120 participants were recruited (Table 1) how-
ever one participant was excluded as the CFDU scan
was performed on a different day to the remainder of
the vascular examination. An additional two participants
were excluded from the targeted screening method due
to missing toe pressure data. Generally the population
was older, in accordance with the inclusion criteria.
There were a high number of participants with diabetes
(61%). Sensitivity of the targeted method (62%, 95% CI
47.17–75.35) was higher than the AHA method (49%,
95% CI 34.75–63.40), however specificity of the AHA
method (94%, 95% CI 85.62–98.37) was higher than the
targeted screening method (85%, 95% CI 74.26–92.60)
(Table 2). Overall the diagnostic accuracy of both
methods were similar, with the AHA screening method
74% diagnostic accuracy and the targeted screening
method 73% diagnostic accuracy.
Discussion
This study investigated whether diagnostic accuracy of
lower limb vascular screening for PAD can be achieved
using a targeted version of current guidelines designed
to reduce the time taken to perform a vascular assess-
ment. The results of this study indicate that the targeted
method had a higher sensitivity for PAD than when tests
were conducted in accordance with the AHA guidelines,
however lower specificity. Overall the two methods had
almost identical diagnostic accuracy (AHA method 74%,
Fig. 2 American Heart Association guideline for non-invasive
peripheral vascular screening
Table 1 Participant information
Total participants (N) 119
Males n (%) 75 (63.02)
Females n (%) 44 (36.97)
Age Range (Years) 53–92
Diabetes n (%) 73 (61.34)
Mean Age (years) 73.1 (SDA 7.2)
Incompressible ankle pressure n (%) 16 (13.44)
Distal PAD n (%) 37 (31.09)
Proximal PAD n (%) 7 (5.88)
Distal & Proximal PAD n (%) 7 (5.88)
PAD n (%) 51 (42.85)
Proximal Occlusions n (%) 1 (0.84)
Distal Occlusions n (%) 40 (33.61)
A = standard deviation, PAD Peripheral arterial disease
Table 2 Results
Results table







Sensitivity 62.00 47.17 to 75.35 49.02 34.75 to 63.40
Specificity 85.07 74.26 to 92.60 94.12 85.62 to 98.37
Positive predictive value 75.61 2.25 to 7.66 86.21 68.34 to 96.11
Negative Predictive Value 75.00 0.31 to 0.65 71.11 60.60 to 80.18
Positive likelihood ratio 4.15b 2.25 to 7.66 8.33a 3.09 to 22.45
Negative likelihood ratio 0.45b 0.31 to 0.65 0.54 0.41 to 0.71
Diagnostic Accuracy 73.94 74.78
aImportant likelihood ratio bMay be important likelihood ratio
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targeted method 73%). Although the ABI has been
shown to have good sensitivity and excellent specificity
across the general population [10] our recent research
suggests uptake of the test by podiatrists is poor, with
the time associated with performing the test cited as one
of the most common reasons for this [2]. Performing an
ABI requires two ankle pressures per limb (dorsalis pedis
and posterior tibial). The targeted method we have pro-
posed increases the number of people who have a TBI
performed as the initial screening test. A TBI is quicker
to perform due to the need for only one toe pressure per
limb to be taken. In addition the targeted method en-
sures there will rarely be a time that clinicians need to
perform more than one form of lower limb pressure
measurement in a single testing session. Both changes
are likely to reduce the amount of time needed to per-
form objective non-invasive vascular testing.
Current evidence suggests podiatrists rely on subject-
ive findings including pulse palpation and visual appear-
ance to identify PAD, while objective assessment is often
limited to CWD which we have shown to have poor reli-
ability [2, 15]. The method we have developed offers a
potential mechanism to improve the diagnostic accuracy
of vascular assessments currently performed by podia-
trists by targeting the type of objective test to be used
using patient medical history. In addition, increasing the
use of the TBI, which has been shown to have high reli-
ability in diabetes and non diabetes cohorts for initial
testing for PAD [16], offers a more time efficient object-
ive test that may be more widely adopted in clinical
practice. There is also growing evidence that tests such
as the TBI may be a valuable adjunct to clinical practice
and could be more widely used, particularly in popula-
tions at risk of foot complications [17].
Of note our study demonstrates that neither screening
method yielded a very high level of diagnostic accuracy,
which re-enforces the difficulty of non-invasive lower
limb vascular assessment in populations at risk of PAD.
Further investigation into the diagnostic accuracy of
non-invasive vascular assessment testing methods
should be undertaken to ascertain what testing should
be performed in populations at risk of PAD. The diag-
nostic accuracy of both the ABI and TBI should be fur-
ther elucidated using gold standard imaging as a
reference standard. Further research that helps guide
clinical practice could facilitate increased efficiency and
increased accuracy when conducting vascular assess-
ments, reducing the number of undiagnosed cases of
PAD and ensuring timely intervention and appropriate
management to prevent complications such as ulceration
and infection and amputation.
The results of this study need to be considered in light
of some significant limitations. The accuracy of both
screening tools relies upon the individual accuracy of
each diagnostic test. Each of the included tests, ABI and
TBI have their own limitations with accuracy. The ABI
in particular has been shown to have limited diagnostic
accuracy in populations at risk of PAD. The reference
standard used, CFDU, whilst a valid form of diagnostic
imaging, and used extensively clinically, also has limita-
tions with diagnostic accuracy. Ideally angiography
should be used as a reference standard however due to
the prospective nature of the data collection for this
study this was not possible. Future research should use
retrospective data and use the gold standard in vascular
imaging, angiography as a reference standard.
Conclusion
Modification of current international guidelines based
on medical history to reduce the time burden of lower
limb vascular assessment in clinical practice yields simi-
lar diagnostic accuracy to assessment undertaken in ac-
cordance with the guidelines. This study highlights the
difficulties in obtaining accuracy in lower limb vascular
assessment in at risk populations and clinicians should
consider using the TBI as an alternate screening tool
given its higher level of accuracy and predictive
capabilities.
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